The effectiveness of telemedicine monitoring on the HbA1c (the glycated hemoglobin) level reduce in patients with diabetes: clinical and economic issues
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Telehealth is becoming increasingly relevant and in demand as a technologically advanced area in healthcare. The telehealth approach in the management of patients with diabetes mellitus (DM) has the potential to improve disease management. Objective. To analyze the effectiveness of telehealth methods in correcting the level of glycated hemoglobin in patients with type 1 and type 2 diabetes mellitus. Materials and methods. We searched for meta-analyses with the keywords “telehealth” AND “diabetes” AND “meta-analysis” in the MEDLINE database (PubMed) and the words “telemedicine”, “diabetes”, “meta-analysis” in the RSCI database (eLibrary) until March 1, 2025. Results. The analysis includes 19 papers evaluating the use of telehealth technologies for the treatment of patients with diabetes. The effectiveness of telehealth in reducing the level of glycated hemoglobin ranged from –0.18% to –0.64% compared to traditional control (face-to-face visits of patients). Conclusion. Telehealth technologies can be effective in reducing glycated hemoglobin levels in patients with type 1 and type 2 diabetes mellitus; however, additional studies on the clinical and cost-effectiveness of telehealth monitoring are required to justify its wider introduction into practice.
Fields of Study & Subjects
Telemedicine and Telehealth Implementation
Diabetes Management and Research
Diabetes Management and Education
Publication details
- Journal / source
- Russian Journal of Preventive Medicine
- Volume
- 29
- Issue
- 3
- Pages
- 116–116
- Publication date
- 27 March 2026
- Language
- EN